Press Tag: Clarametyx Biosciences

Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Top Tech Companies In Ohio To Watch in 2025
Nationwide Children’s infection-busting treatment gets pivotal tests
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Startups to Watch: These Central Ohio Companies Could Take Off in 2023
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC